Why the study?
An increasing number of cancer patients present with acute CV diseases related to cancer or cancer treatment, requiring acute cardiac care specialists to recognize and manage these complications.
This consensus document provides a framework for the multidisciplinary management of acute coronary syndromes and acute pericardial diseases in cancer patients.
Answers are grounded in this paper and cite their sources.
Alerts acute cardiac teams to rising cancer-related CV emergencies; leaves optimal multidisciplinary protocols open.
Advances in treatment, common cardiovascular (CV) risk factors and the ageing of the population have led to an increasing number of cancer patients presenting with acute CV diseases. These events may be related to the cancer itself or the cancer treatment. Acute cardiac care specialists must be aware of these acute CV complications and be able to manage them. This may require an individualized and multidisciplinary approach. We summarize the most common acute CV complications of cytotoxic, targeted, and immune-based therapies. This is followed by a proposal for a multidisciplinary approach where acute cardiologists work close together with the treating oncologists, haematologists, and radiation specialists, especially in situations where immediate therapeutic decisions are needed. In this first part, we further focus on the management of acute coronary syndromes and acute pericardial diseases in patients with cancer.
No takes yet. Share an insight, caveat, or question.
Gevaert et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: